Researchers report development of epigenetic and lifespan-prediction clocks in zebra finches

Researchers developed an epigenetic clock and a post-sampling survival predictor in zebra finches, showing that longitudinal rates of epigenetic change, rather than static epigenetic age acceleration, predict remaining lifespan in an avian model.

Researchers at the Groningen Institute for Evolutionary Life Sciences analyzed 100 longitudinal whole-genome methylomes from 50 captive zebra finches monitored until their natural deaths.

The team identified 29 CpG sites where DNA methylation changed significantly with age, noting genome-wide hypomethylation that progressed faster in birds with shorter lifespans.

Using 119 CpG sites, the researchers constructed an epigenetic clock predicting chronological age with a median absolute deviation of 0.68 years (approximately 8.2% of the maximum lifespan in the cohort).

While static epigenetic age acceleration did not predict lifespan, the within-individual rate of change in epigenetic age did predict remaining lifespan.

The researchers also trained a 'doom' clock designed to predict post-sampling lifespan, which successfully predicted the remaining lifespan of the birds.

The study provides the first evidence that DNA methylation can track biological aging and predict remaining lifespan in an avian model species.

The findings suggest that early-life environments, such as brood size, shape long-term biological aging trajectories through the epigenome.

The research highlights the critical importance of longitudinal sampling, demonstrating that the dynamic rate of epigenetic change is a more reliable predictor of lifespan than a single, static measure of age acceleration.

This development supports a methodological shift in the longevity diagnostics sector toward longitudinal, rate-of-change epigenetic measurements over static, single-point biomarkers.

The validation of a survival-predicting 'doom' clock in an avian model may inform the translation of dynamic epigenetic algorithms to mammalian and pre-clinical drug-screening models.

Further longitudinal studies in mammalian models to determine if within-individual rates of epigenetic aging are similarly superior to static age acceleration in predicting chronological mortality.

The potential incorporation of rate-of-change algorithms into commercial epigenetic testing platforms.